Skip to content
Disclosery

LAV Fund VI, L.P.

Reporting owner on Forms 3, 4 and 5, CIK 1836170.

LAV Fund VI, L.P. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-29.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ADARx Pharmaceuticals, Inc. CIK 180236910% owner12026-09-29

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+8,908,7758,908,775Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+1,667,46910,576,244Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+513,06711,089,311Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+153,86811,243,179Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+307,738307,738Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+307,738307,738Form 4
ADARx Pharmaceuticals, Inc. Series A Preferred Stock, derivative2026-09-28C converted-10,438,412$00Form 4
ADARx Pharmaceuticals, Inc. Series B Preferred Stock, derivative2026-09-28C converted-1,953,774$00Form 4
ADARx Pharmaceuticals, Inc. Series B-1 Preferred Stock, derivative2026-09-28C converted-601,161$00Form 4
ADARx Pharmaceuticals, Inc. Series C Preferred Stock, derivative2026-09-28C converted-180,288$00Form 4
ADARx Pharmaceuticals, Inc. Series C Preferred Stock, derivative2026-09-28C converted-360,577$00Form 4
ADARx Pharmaceuticals, Inc. Series C Preferred Stock, derivative2026-09-28C converted-360,577$00Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001231919-26-001406 ADARx Pharmaceuticals, Inc.2026-09-29